Cannabis, Weight, and Weight-Related Behaviors.

IF 9.5 2区医学 Q1 ENDOCRINOLOGY & METABOLISM

Current Obesity Reports Pub Date : 2025-05-08 DOI:10.1007/s13679-025-00633-z

Kasey P S Goodpaster

{"title":"Cannabis, Weight, and Weight-Related Behaviors.","authors":"Kasey P S Goodpaster","doi":"10.1007/s13679-025-00633-z","DOIUrl":null,"url":null,"abstract":"Purpose of review: Review recent research regarding the relationship between cannabis use, weight, eating behaviors, eating disorders, and physical activity.Recent findings: Cannabis, particularly the cannabinoid Δ9-tegrahydrocannabinol (THC), is associated with increased appetite, food cravings, overconsumption, and decreased physical activity. Cannabidiol (CBD) appears to be associated with decreased appetite. While cannabis use is not correlated with binge eating, cannabis use disorder is associated with loss of control eating. Despite cannabis' association with unhealthy eating and sedentary behavior, most studies suggest that cannabis use is not associated with weight gain, or may even facilitate weight loss. The state of the literature regarding the relationship between cannabis, weight, and weight-related behaviors is complex. Most studies do not differentiate between cannabinoid profiles, routes of administration, or whether cannabis use is problematic. Patients presenting for weight management should be cautioned about cannabis, particularly THC, potentially increasing risk of unhealthy eating and activity patterns.","PeriodicalId":10846,"journal":{"name":"Current Obesity Reports","volume":"14 1","pages":"40"},"PeriodicalIF":9.5000,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12062030/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Obesity Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13679-025-00633-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Review recent research regarding the relationship between cannabis use, weight, eating behaviors, eating disorders, and physical activity.

Recent findings: Cannabis, particularly the cannabinoid Δ9-tegrahydrocannabinol (THC), is associated with increased appetite, food cravings, overconsumption, and decreased physical activity. Cannabidiol (CBD) appears to be associated with decreased appetite. While cannabis use is not correlated with binge eating, cannabis use disorder is associated with loss of control eating. Despite cannabis' association with unhealthy eating and sedentary behavior, most studies suggest that cannabis use is not associated with weight gain, or may even facilitate weight loss. The state of the literature regarding the relationship between cannabis, weight, and weight-related behaviors is complex. Most studies do not differentiate between cannabinoid profiles, routes of administration, or whether cannabis use is problematic. Patients presenting for weight management should be cautioned about cannabis, particularly THC, potentially increasing risk of unhealthy eating and activity patterns.

查看原文本刊更多论文

大麻、体重和与体重相关的行为。

综述目的：综述最近关于大麻使用、体重、饮食行为、饮食失调和身体活动之间关系的研究。最近的研究发现：大麻，特别是大麻素Δ9-tegrahydrocannabinol (THC)，与食欲增加、对食物的渴望、过度消费和身体活动减少有关。大麻二酚（CBD）似乎与食欲下降有关。虽然大麻使用与暴饮暴食无关，但大麻使用障碍与饮食失控有关。尽管大麻与不健康的饮食和久坐不动的行为有关，但大多数研究表明，使用大麻与体重增加无关，甚至可能有助于减肥。关于大麻、体重和体重相关行为之间关系的文献状况是复杂的。大多数研究没有区分大麻素概况，给药途径，或者大麻使用是否有问题。要求控制体重的患者应谨慎使用大麻，特别是四氢大麻酚，这可能会增加不健康饮食和活动模式的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Obesity Reports Medicine-General Medicine

CiteScore

16.40

自引率

1.10%

发文量

期刊介绍： The main objective of Current Obesity Reports is to provide expert review articles on recent advancements in the interdisciplinary field of obesity research. Our aim is to offer clear, insightful, and balanced contributions that will benefit all individuals involved in the treatment and prevention of obesity, as well as related conditions such as cardiovascular diseases, endocrine disorders, gynecological issues, cancer, mental health, respiratory complications, and rheumatological diseases. We strive to redefine the way knowledge is expressed and provide organized content for the benefit of our readership.